Brian M. Silver, Chief Financial Officer at TScan Therapeutics, Inc. (TCRX), bought 5,885 shares at $8.48 ($50K) on 2021-09-09, disclosed to the SEC on 2021-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TCRX | BUY | 2021-09-22 | $32K | — | Filing → |
| TCRX | BUY | 2021-07-22 | $15K | — | Filing → |